Summary
Introduction
Seizures are known to perturb circadian rhythms in humans as well as in animal models of epilepsy. However, it is unknown whether treatment of the underlying epilepsy restores normal biological rhythms. We asked whether: (1) seizure activity is characterized by diurnal rhythmicity; (2) chronically epileptic mice exhibit impaired activity-rest rhythms; and (3) treatment with the anticonvulsant ketogenic diet (KD) improves such perturbations.
Methods
Chronically epileptic Kcna1-null mice were fed either a standard diet or KD for 4 wks and subjected to continuous video-EEG and actigraphy monitoring for 3–5 days to assess seizure activity and rest-activity cycles.
Results
Seizure activity in Kcna1-null mice demonstrated diurnal rhythmicity, peaking at zeitgeber (ZT) 2.30±1.52. Activity-rest rhythms of epileptic mice were significantly disrupted. Whereas locomotor activity for wild-type mice peaked at ZT15.45±0.28 (ZT14:26–ZT16:51), peak activity of epileptic mice was more unpredictable, occurring over a 12.4hr range (ZT06:33–ZT18:57). In 6 of 9 epileptic mice, peak activity was delayed to ZT17.42±0.38, while peak activity was advanced to ZT10.00±1.26 in the remaining mice. Treatment with the KD abolished seizure periodicity and restored the activity-rest rhythm to values resembling those of wild-type mice (i.e. activity peaking at ZT16.73±0.67).
Conclusions
Kcna1-null mice experience seizures with 24-hr periodicity and impaired circadian behavior. KD reduces the number and periodicity of seizures and restores normal behavioral rhythms, suggesting that this non-pharmacological therapy may benefit biological rhythm disturbances in epileptic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.